Birdwatch Note
2023-06-02 00:28:13 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Studies by the University of Oxford have found that the risk of rare blood clots is several times higher with COVID-19 than for vaccination: https://www.ox.ac.uk/news/2021-04-15-risk-rare-blood-clotting-higher-covid-19-vaccines Whilst this article presents an unverified claim about an individual, vaccines are studied through rigorous Randomised Control Trials: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8165083/
Written by 1990994178F2965E44EC3711F4FF39E19782D705B15E92F7A6C4D1383B9D96FE
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1664400396624773121
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1664428670067384321
- noteId - 1664428670067384321
- participantId -
- noteAuthorParticipantId - 1990994178F2965E44EC3711F4FF39E19782D705B15E92F7A6C4D1383B9D96FE Participant Details
- createdAtMillis - 1685665693190
- tweetId - 1664400396624773121
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Studies by the University of Oxford have found that the risk of rare blood clots is several times higher with COVID-19 than for vaccination: https://www.ox.ac.uk/news/2021-04-15-risk-rare-blood-clotting-higher-covid-19-vaccines Whilst this article presents an unverified claim about an individual, vaccines are studied through rigorous Randomised Control Trials: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8165083/
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2023-06-02 00:28:13 UTC (1685665693190) |
1969-12-31 23:59:59 UTC (-1) |
2023-06-02 02:42:15 UTC (1685673735983) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
Note Ratings
rated at | rated by | |
2023-06-02 18:55:09 -0500 | Rating Details | |
2023-06-02 18:46:56 -0500 | Rating Details | |
2023-06-02 12:55:26 -0500 | Rating Details | |
2023-06-02 11:32:52 -0500 | Rating Details | |
2023-06-02 11:16:40 -0500 | Rating Details | |
2023-06-02 10:56:42 -0500 | Rating Details | |
2023-06-02 09:06:31 -0500 | Rating Details | |
2023-06-02 09:02:02 -0500 | Rating Details | |
2023-06-02 08:45:06 -0500 | Rating Details | |
2023-06-02 08:36:05 -0500 | Rating Details | |
2023-06-02 08:02:47 -0500 | Rating Details | |
2023-06-02 07:15:44 -0500 | Rating Details | |
2023-06-02 07:12:27 -0500 | Rating Details | |
2023-06-02 07:09:01 -0500 | Rating Details | |
2023-06-02 06:44:48 -0500 | Rating Details | |
2023-06-02 06:44:22 -0500 | Rating Details | |
2023-06-02 06:34:28 -0500 | Rating Details | |
2023-06-02 06:31:39 -0500 | Rating Details | |
2023-06-02 05:44:22 -0500 | Rating Details | |
2023-06-02 05:22:12 -0500 | Rating Details | |
2023-06-02 04:43:04 -0500 | Rating Details | |
2023-06-02 04:29:53 -0500 | Rating Details | |
2023-06-02 04:21:10 -0500 | Rating Details | |
2023-06-02 03:45:53 -0500 | Rating Details | |
2023-06-02 03:42:28 -0500 | Rating Details | |
2023-06-02 03:33:52 -0500 | Rating Details | |
2023-06-02 02:59:10 -0500 | Rating Details | |
2023-06-02 02:53:44 -0500 | Rating Details | |
2023-06-02 02:35:43 -0500 | Rating Details | |
2023-06-02 02:02:34 -0500 | Rating Details | |
2023-06-02 02:01:26 -0500 | Rating Details | |
2023-06-02 01:53:11 -0500 | Rating Details | |
2023-06-02 01:47:41 -0500 | Rating Details | |
2023-06-02 01:37:12 -0500 | Rating Details | |
2023-06-02 01:31:48 -0500 | Rating Details | |
2023-06-02 01:30:08 -0500 | Rating Details | |
2023-06-02 01:07:24 -0500 | Rating Details | |
2023-06-02 00:47:22 -0500 | Rating Details | |
2023-06-02 00:32:53 -0500 | Rating Details | |
2023-06-02 00:30:43 -0500 | Rating Details | |
2023-06-02 00:09:54 -0500 | Rating Details | |
2023-06-01 23:19:33 -0500 | Rating Details | |
2023-06-01 23:13:42 -0500 | Rating Details | |
2023-06-01 23:05:11 -0500 | Rating Details | |
2023-06-01 22:43:19 -0500 | Rating Details | |
2023-06-01 22:26:24 -0500 | Rating Details | |
2023-06-01 22:26:05 -0500 | Rating Details | |
2023-06-01 22:25:17 -0500 | Rating Details | |
2023-06-01 22:06:12 -0500 | Rating Details | |
2023-06-01 21:42:47 -0500 | Rating Details | |
2023-06-01 21:32:13 -0500 | Rating Details | |
2023-06-01 21:29:13 -0500 | Rating Details | |
2023-06-01 21:23:02 -0500 | Rating Details | |
2023-06-01 21:07:55 -0500 | Rating Details | |
2023-06-01 20:44:27 -0500 | Rating Details | |
2023-06-01 20:35:14 -0500 | Rating Details | |
2023-06-01 20:33:47 -0500 | Rating Details | |
2023-06-01 20:28:28 -0500 | Rating Details | |
2023-06-01 20:16:27 -0500 | Rating Details | |
2023-06-01 20:08:53 -0500 | Rating Details | |
2023-06-01 19:55:53 -0500 | Rating Details | |
2023-06-01 19:46:22 -0500 | Rating Details | |
2023-06-01 19:44:09 -0500 | Rating Details | |
2023-06-01 19:40:45 -0500 | Rating Details | |
2023-06-03 00:45:25 -0500 | Rating Details | |
2023-06-02 20:56:06 -0500 | Rating Details | |
2023-06-02 20:00:59 -0500 | Rating Details | |
2023-06-02 19:32:57 -0500 | Rating Details |